The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis

Abstract

Background: Although the efficacy and safety of monotherapy in the treatment of benign prostatic hyperplasia (BPH) have been established clinically, the efficacy and safety of dutasteride and finasteride have not been compared. The aim was to systematically evaluate the efficacy and safety of the two drugs in the treatment of BPH to provide medical evidence for clinical treatment.Methods: A search of relevant articles was conducted using the electronic databases PubMed, Embase, Medline, Cochrane Library, China Academic Journals Full-text Database (CJFD), Chinese Science and Technology Journal Database (VIP) and Wanfang Database. Randomized controlled trials (RCTs) comparing the efficacy of finasteride (control group) with that of dutasteride (experimental group) in the treatment of BPH with respect to the International Prostate Symptom Score (IPSS), the maximum urinary flow rate (Qmax), prostate volume (PV), quality of life (QOL), serum prostate-specific antigen (PSA) level and adverse drug reactions (ADRs) after medication were strictly evaluated and considered for inclusion. Rev Man 5.4 software was used for the meta-analysis.Results: A total of 8 RCTs were included, with a total of 2,116, patients. The meta-analysis showed that compared with finasteride, dutasteride can effectively improve the Qmax of patients with BPH [mean difference (MD) =0.

The Potential of Dutasteride for Treating Multidrug-Resistant Candida auris Infection

“…Remarkably, the occurrence of the majority of drug-induced sexual side effects declined in individuals who were administered dutasteride consistently over the course of 48 months. Overall, long-term treatment with dutasteride does not result in an increased occurrence of negative outcomes, and patients generally adhere well to the treatment [ 59 , 60 ]. It is important to take these data into account when evaluating the future development of high dosages of dutasteride to treat individuals with C. auris infection.…”

Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia

“…; (IV) improving the QoL. And the treatment methods include drug and surgical therapy ( 4 , 33 ). There are plenty of side effects and risks of surgical therapy, such as bleeding, infection, urinary incontinence, frequent urination, urethral stricture, erectile dysfunction, etc.…”

Treatment of refractory hematospermia with Finasteride: A prospective placebo-controlled study

“…Finasteride is approved for the management of BPH. Finasteride inhibits the conversion of testosterone to dihydrotestosterone and is used for treating benign prostatic hyperplasia, haematuria of prostatic origin 7 . Finasteride may lead to some side effects, such as abdominal pain, back pain, decreased libido, and decreased volume of ejaculate.…”